関連する実験動画
Updated: Jan 22, 2026

09:00
Detection of Protein Ubiquitination
Published on: August 19, 2009
43.6K
転移におけるユビキチン化駆動型プロテオスタシスの再プログラム
Dongping Wei1, Jiayan Chen2, Yaping Xu3
1Medical Research Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|January 21, 2026
まとめ
研究者らは、DCAF12とTRiC/CCTシャペロニンが関与する新しいがん転移経路を発見した。この軸はタンパク質折り畳みを強化することによってがんの適応を促進し、がんを標的とする新しい治療標的を提供する。
科学分野:
- 細胞生物学
- 分子生物学
- がん研究
背景:
- 転移はがんの死亡率を駆動するため、プロテオーム適応が必要である。
- ユビキチン化は通常、タンパク質分解のシグナルとなるが、転移におけるその役割は複雑である。
- Cullin 4-RINGユビキチンリガーゼ複合体は、細胞調節において役割を果たす。
研究 の 目的:
- 転移を促進する非古典的ユビキチン化メカニズムを解明すること。
- DCAF12をがん細胞適応の主要な調節因子として同定すること。
- DCAF12-TRiC/CCT軸を治療標的として探求すること。
主な方法:
- Cullin 4-RINGユビキチンリガーゼ複合体におけるDCAF12の役割を調査した。
- TRiC/CCTシャペロニンサブユニットの非分解性ユビキチン化を分析した。
- シャペロニン機能とタンパク質折り畳みに対するDCAF12媒介ユビキチン化の影響を調べた。
主要な成果:
- DCAF12はTRiC/CCTサブユニットの非分解性ユビキチン化を媒介する。
- このユビキチン化はTRiC/CCTをアロステリックに活性化し、折り畳み能力を向上させる。
- DCAF12-TRiC/CCT軸は、転移細胞におけるプロテオーム再プログラミングを促進する。
結論:
- DCAF12-TRiC/CCT軸は、転移における適応性プロテオスタシスに不可欠である。
- DCAF12は、シャペロニン機能の「DCAFドーム」調節因子の新しいクラスを表す。
- この軸を標的とすることは、進行がんに対抗するための治療戦略を提供する。
関連する概念動画
Metastasis
6.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K
Introduction to Nuclear Reprogramming
2.3K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
2.3K
Methods of Nuclear Reprogramming
2.1K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.1K
ATP Driven Pumps I: An Overview
9.7K
ATP-driven pumps, also known as transport ATPases, are integral membrane proteins. They have binding sites for ATP located on the membrane's cytosolic side and the ion-conducting domain in the transmembrane region. These pumps use the free energy released from ATP hydrolysis to move the solutes across cell membranes against an electrochemical gradient.
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
9.7K
Somatic to iPS Cell Reprogramming
2.6K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.6K
ATP Driven Pumps II: P-type Pumps
6.2K
The P-type pumps are a large family of integral membrane transporter ATPases. They are divided into five major types based on substrate specificity, from I to V.
A typical P-type pump has three cytosolic domains: nucleotide-binding (N), phosphorylation (P), and activator (A) domains. These domains are connected to the membrane-spanning helices by short amino acid segments. ATP hydrolysis and covalent phosphoenzyme intermediate formation are crucial parts of the catalytic cycle. At the highly...
A typical P-type pump has three cytosolic domains: nucleotide-binding (N), phosphorylation (P), and activator (A) domains. These domains are connected to the membrane-spanning helices by short amino acid segments. ATP hydrolysis and covalent phosphoenzyme intermediate formation are crucial parts of the catalytic cycle. At the highly...
6.2K

